An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine

被引:15
|
作者
Langford, JS [1 ]
Sheikh, S [1 ]
机构
[1] Univ Louisville, Dept Emergency Med, Louisville, KY 40292 USA
关键词
D O I
10.1016/S0196-0644(99)80058-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We describe the case of an adolescent girl who received high-dose metoclopramide in combination with oral N-acetylcysteine therapy for acute acetaminophen toxicity. Whole blood-sample analysis for abnormal hemoglobin pigments established the diagnosis of sulfhemoglobinemia. Metoclopramide has been shown to cause sulfhemoglobinemia, particularly when used in repeated high doses. Although N-acetylcysteine alone has not been associated as the cause, we suggest that sulfhemoglobinemia is a potential complication in patients treated with metoclopramide for the nausea that often accompanies oral N-acetylcysteine therapy for acetaminophen toxicity. Cyanosis without respiratory distress should suggest this diagnosis.
引用
收藏
页码:538 / 541
页数:4
相关论文
共 50 条
  • [31] HIGH DOSE ACETAMINOPHEN WITH N-ACETYLCYSTEINE RESCUE FOR UNRESECTABLE HEPATOBLASTOMA
    Baker, Katherine
    Koole, William
    Pugmire, Brian
    Tamura, Dauglas
    Ozeran, Daniel
    Fernandez, Karen
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [32] METOCLOPRAMIDE EFFECT ON ACETAMINOPHEN INTOXICATION AND RESPONSE TO N-ACETYLCYSTEINE TREATMENT
    TONG, T
    BANNER, W
    GRAHAM, A
    LUND, M
    VETERINARY AND HUMAN TOXICOLOGY, 1984, 26 (05) : 407 - 407
  • [33] Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis - Adjunctive therapy to maintenance immunosuppression
    Behr, J
    Maier, K
    Degenkolb, B
    Krombach, F
    Vogelmeier, C
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) : 1897 - 1901
  • [34] EFFECT OF HIGH-DOSE N-ACETYLCYSTEINE ON GLUTATHIONE AND CYSTEINE LEVELS IN BRONCHOALVEOLAR LAVAGE AND LUNG-TISSUE
    MORRISON, D
    BRIDGEMAN, MME
    MARSDEN, M
    MACNEE, W
    THORAX, 1992, 47 (03) : P246 - P246
  • [35] BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE
    TAYLOR, WB
    BATEMAN, DN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (03) : P296 - P296
  • [36] N-ACETYLCYSTEINE FOR TREATING ADOLESCENT ALCOHOL USE
    Kirkland, A. E.
    Browning, B. D.
    Green, R.
    Liu, H.
    Squeglia, L. M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 44A - 44A
  • [37] Comment on Single bag high dose intravenous N-acetylcysteine associated with decreased hepatotoxicity compared to triple bag intravenous N-acetylcysteine in high-risk acetaminophen ingestions
    Hodgson, S. E.
    Wong, A.
    CLINICAL TOXICOLOGY, 2022, 60 (05) : 662 - 663
  • [38] Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients
    Haase, Michael
    Haase-Fielitz, Anja
    Bagshaw, Sean M.
    Reade, Michael C.
    Morgera, Stanislao
    Seevenayagam, Siven
    Matalanis, George
    Buxton, Brian
    Doolan, Laurie
    Bellomo, Rinaldo
    CRITICAL CARE MEDICINE, 2007, 35 (05) : 1324 - 1331
  • [39] TARDIVE-DYSKINESIA ASSOCIATED WITH HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE
    BREITBART, W
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08): : 518 - 518
  • [40] N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney
    Cusumano, G.
    Romagnoli, J.
    Liuzzo, G.
    Ciavarella, L. P.
    Severino, A.
    Copponi, G.
    Manchi, M.
    Giubilato, S.
    Zannoni, G. F.
    Stigliano, E.
    Caristo, M. E.
    Crea, F.
    Citterio, F.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (09) : 2757 - 2762